These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18891445)

  • 21. The mode of action of proguanil and related antimalarial drugs.
    RYLEY JF
    Br J Pharmacol Chemother; 1953 Dec; 8(4):424-30. PubMed ID: 13115632
    [No Abstract]   [Full Text] [Related]  

  • 22. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in antimalarial prescriptions in Australia, 2005 to 2009.
    Leggat PA
    J Travel Med; 2012 Dec; 19(6):357-60. PubMed ID: 23379705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experiments with antimalarial drugs in man. V. Experiments with an active metabolite of proguanil and an active metabolite of 5943.
    ROBERTSON GI
    Trans R Soc Trop Med Hyg; 1957 Nov; 51(6):488-92. PubMed ID: 13496181
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversal of paludrine toxicity by non-ionic detergents in lactic acid bacteria and yeast.
    RAMAN TS; SHANMUGASUNDARAM ER
    Ann Biochem Exp Med; 1962 Jan; 22():21-2. PubMed ID: 14490083
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of B. T. and M. T. malaria with paludrine; temperature charts and diagrams illustrating plasma and urinary concentration of paludrine.
    MAEGRAITH BG; ADAMS AR
    Trans R Soc Trop Med Hyg; 1946 Aug; 40():1. PubMed ID: 20998604
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimalarial activities of triazine metabolites of chlorguanide and dichlorguanide.
    SCHMIDT LH; LOO TL; FRADKIN R; HUGHES HB
    Proc Soc Exp Biol Med; 1952 Jun; 80(2):367-70. PubMed ID: 14949053
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children.
    Lell B; Luckner D; Ndjavé M; Scott T; Kremsner PG
    Lancet; 1998 Mar; 351(9104):709-13. PubMed ID: 9504515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proguanil, the isolation of a metabolite with high antimalarial activity.
    CROWTHER AF; LEVI AA
    Br J Pharmacol Chemother; 1953 Mar; 8(1):93-7. PubMed ID: 13066702
    [No Abstract]   [Full Text] [Related]  

  • 30. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.
    Thevis M; Geyer H; Thomas A; Tretzel L; Bailloux I; Buisson C; Lasne F; Schaefer MS; Kienbaum P; Mueller-Stoever I; Schänzer W
    J Pharm Biomed Anal; 2015 Nov; 115():208-13. PubMed ID: 26226108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)].
    Angles A; Bagheri H; Montastruc JL; Magnaval JF;
    Presse Med; 2003 Jan; 32(3):106-13. PubMed ID: 12610379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic and oxidative status of human lymphocytes after exposure to clinically relevant concentrations of antimalarial drugs atovaquone and proguanil hydrochloride in vitro.
    Dinter D; Gajski G; Domijan AM; Garaj-Vrhovac V
    Fundam Clin Pharmacol; 2015 Dec; 29(6):575-85. PubMed ID: 26434663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phototoxic reaction associated with Malarone (atovaquone/proguanil) antimalarial prophylaxis.
    Amelot A; Dupouy-Camet J; Jeanmougin M
    J Dermatol; 2014 Apr; 41(4):346-8. PubMed ID: 24612343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New antimalarial drugs].
    Ambroise-Thomas P
    Rev Prat; 1998 Feb; 48(3):287-90. PubMed ID: 9781076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations.
    Kaneko A; Bergqvist Y; Taleo G; Kobayakawa T; Ishizaki T; Björkman A
    Pharmacogenetics; 1999 Jun; 9(3):317-26. PubMed ID: 10471063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria.
    Kain KC
    BioDrugs; 2003; 17 Suppl 1():23-8. PubMed ID: 12785875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Paludrine (proguanil, chlorguanide) in clinical prophylaxis].
    van GOOR WT; LODENS JG
    Med Maandbl; 1950 Mar; 3(3):103-21. PubMed ID: 24537268
    [No Abstract]   [Full Text] [Related]  

  • 39. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potentiation of the antimalarial activity of chloroguanide by p-aminobenzoic acid competitors.
    GREENBERG J
    J Pharmacol Exp Ther; 1949 Oct; 97(2):238-42. PubMed ID: 15391935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.